Takeda Pharmaceutical NYSE: TAK has filed 13-F forms with the SEC as an investor. Takeda Pharmaceutical is itself a publicly traded company. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. For more information on Takeda Pharmaceutical stock, visit the Takeda Pharmaceutical stock profile here.
Investment Activity
- Takeda Pharmaceutical has $19.55 million in total holdings as of June 30, 2025.
- Takeda Pharmaceutical owns shares of 11 different stocks, but just 2 companies or ETFs make up 80% of its holdings.
- About 35.36% of the portfolio was sold this quarter.
- This quarter, Takeda Pharmaceutical has purchased 11 new stocks and bought additional shares in 0 stocks.
- Takeda Pharmaceutical sold shares of 1 stock and completely divested from 0 stocks this quarter.
Largest Holdings
- American Well Corporation
- $691,050
Largest Sales this Quarter
